Literature DB >> 9481787

Clinical correlations of patterns of placental pathology in preterm pre-eclampsia.

C M Salafia1, J C Pezzullo, A Ghidini, J A Lopèz-Zeno, S S Whittington.   

Abstract

The objective of this study was to determine if placental histopathology patterns are associated with clinical features of preterm pre-eclampsia. A 1989-1993 database of consecutive non-anomalous singleton livebirths delivered at 22-32 weeks gestation excluding cases of maternal diabetes mellitus and chronic hypertension included 74 cases of pre-eclampsia. Placentae were scored for uteroplacental vascular lesions and lesions of chronic inflammation and coagulation. Thirteen lesion patterns identified by factor analysis were studied in relation to the clinical features. Severe maternal proteinuria was related to placental chronic inflammation, while lower maternal antepartum platelet counts were related to placental abruption and infarct. Lower birthweight percentile and lighter placentae were related directly to uteroplacental vascular lesions. Diagnosis of HELLP and coagulopathy were less common when chronic inflammation scores were high. Serologic studies related to autoimmunity and maternal blood pressures were unrelated to placental histopathology factors. It is concluded that features of maternal and fetal compromise in preterm pre-eclampsia are related to placental histopathology patterns.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9481787     DOI: 10.1016/s0143-4004(98)90100-x

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  16 in total

1.  Frequency and clinical significance of placental histological lesions in an unselected population at or near term.

Authors:  Sangeeta Pathak; Christoph C Lees; Gerald Hackett; Flora Jessop; Neil J Sebire
Journal:  Virchows Arch       Date:  2011-10-27       Impact factor: 4.064

2.  Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.

Authors:  Karoline Mayer-Pickel; Katharina Eberhard; Uwe Lang; Mila Cervar-Zivkovic
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

3.  Placental vascular pathology findings and pathways to preterm delivery.

Authors:  R Kelly; C Holzman; P Senagore; J Wang; Y Tian; M H Rahbar; H Chung
Journal:  Am J Epidemiol       Date:  2009-06-09       Impact factor: 4.897

4.  Maternal use of selective serotonin reuptake inhibitors (SSRI) during pregnancy-neonatal outcomes in correlation with placental histopathology.

Authors:  Michal Levy; Michal Kovo; Hadas Miremberg; Noa Anchel; Hadas Ganer Herman; Jacob Bar; Letizia Schreiber; Eran Weiner
Journal:  J Perinatol       Date:  2020-01-27       Impact factor: 2.521

5.  Neonatal morbidity and small and large size for gestation: a comparison of birthweight centiles.

Authors:  Robert D Cartwright; Ngaire H Anderson; Lynn C Sadler; Jane E Harding; Lesley M E McCowan; Christopher J D McKinlay
Journal:  J Perinatol       Date:  2020-02-20       Impact factor: 2.521

6.  Impact of fetal versus perinatal hypoxia on sex differences in childhood outcomes: developmental timing matters.

Authors:  Michael Anastario; Carolyn M Salafia; Garrett Fitzmaurice; Jill M Goldstein
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-02-17       Impact factor: 4.328

7.  Placental pathology varies in hypertensive conditions of pregnancy.

Authors:  Jerzy Stanek
Journal:  Virchows Arch       Date:  2017-10-02       Impact factor: 4.064

8.  The effect of maternal thrombophilia on placental abruption: Histologic correlates.

Authors:  Wendy L Kinzler; Vinay Prasad; Cande V Ananth
Journal:  J Matern Fetal Neonatal Med       Date:  2009-03

Review 9.  Angiogenic factors and preeclampsia.

Authors:  Sharon E Maynard; S Ananth Karumanchi
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

Review 10.  Endoglin: a critical mediator of cardiovascular health.

Authors:  Navin K Kapur; Kevin J Morine; Michelle Letarte
Journal:  Vasc Health Risk Manag       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.